http://www.fpnotebook.com/
Premenstrual SyndromeAka: PMS, Premenstrual Dysphoric Disorder, Late Luteal Phase Dysphoric Disorder
- Epidemiology
- Women who have classic premenstrual symptoms: 30-40%
- Moderate symptoms (Premenstrual Syndrome): 5-10%
- Women who have Premenstrual Dysphoric Disorder: 2-3%
- Severe symptoms interfere with work or activities
- Etiology
- Idiopathic
- Possible mechanisms
- Relative Progesterone deficiency in Luteal Phase
- Prostaglandin excess
- Cyclic decreases in CNS Dopamine and Serotonin
- Premenstrual Estrogen causes Vitamin B6 deficiency
- Vitamin B6 is coenzyme for Dopamine and Serotonin
- Estrogen-mediated sodium retention with fluid shifts
- Increased luteal-phase Insulin to oral carbohydrates
- Diagnosis
- Daily Symptom Diary for at least 2 months
- Symptoms present in each Menstrual Cycle
- Which symptom is most distressing
- Symptoms begin at or after Ovulation
- Symptoms resolve near Menses
- Symptom free period of at least 7 days each cycle
- Symptoms present in each Menstrual Cycle
- Additional History and Exam
- Thorough psychiatric exam during Follicular Phase
- Complete medical history
- Assess nutritional status
- Comorbid factors
- Assess functional Impairment
- Daily Symptom Diary for at least 2 months
- Symptoms
- Timing
- Physical
- Abdominal bloating
- Constipation
- Edema and Weight gain
- Hot Flashes
- Headache
- Breast Pain
- Rhinitis
- Acne Vulgaris
- Palpitations
- Psychological
- Differential Diagnosis
- Mood Disorder (Major Depression, Anxiety)
- Eating Disorder (Anorexia Nervosa, Bulimia)
- Substance Abuse
- Anemia
- Hypothyroidism
- Perimenopause
- Oral Contraceptive adverse effects
- Management Algorithm
- Step 0
- Confirm diagnosis
- Daily symptom diary
- Step 1: Lifestyle modification (50% response)
- Dietary changes
- Low Fat Diet
- Low salt diet (may decrease bloating)
- Decrease simple carbohydrate intake
- Avoid caffeine
- Avoid Alcohol
- Aerobic Exercise regularly
- Bright Light Therapy (10k Lx cool-white fluorescent)
- Get adequate sleep per night (see Sleep Hygiene)
- Other measures
- Relaxation techniques
- Anger management
- Individual and family therapy
- Self-help support group
- Dietary changes
- Step 2: Counseling
- Cognitive Psychotherapy
- Step 3: Dietary Supplementation trial for 3 months
- Calcium Carbonate 1200 mg per day throughout cycle
- Vitamin B6 (Pyridoxine) 100 mg qd throughout cycle
- Needs confirmation with larger studies
- Wyatt (1999) BMJ 318:1375
- Vitamin E 400 to 600 IU qd throughout cycle
- Decreases PMS symptoms (esp. breast tenderness)
- Chasteberry improves breast tenderness, Constipation
- Magnesium 360 mg/day (variable evidence)
- Avoid supplements found not to be efficacious
- Black Cohosh
- Dong Quai
- Evening Primrose Oil
- Progesterone
- Red Clover
- Vitamin A
- Soy products
- Step 4: Oral Contraceptive pill (OCP) trial
- Consider continuing without a week off
- Not uniformly effective in all women
- Relieves only physical symptoms
- Benefit appears to be due to Estrogen component
- Monophasic pill are most appropriate
- Step 5: Consider Symptom directed medication
- Dysphoria with bloating
- Spironolactone 25-100 mg/day during Luteal Phase
- Thiazide Diuretics have not shown benefit
- Breast Tenderness
- See Mastalgia
- Oral Contraceptives
- Danazol 100 mg bid up to 6 cycles
- Risk of masculinization, abnormal LFTs and Lipids
- Dysmenorrhea or Menorrhagia: NSAIDS
- Headaches and Premenstrual Migraines
- Dysphoria with bloating
- Step 6: SSRI trial
- Consider as first-line therapy
- Consider Luteal Phase dosing only
- Days 17-28 or 14 days before anticipated Menses
- Base starting dose on symptom diary
- Fluoxetine (Prozac)
- Daily: 20-40 mg qAM OR
- Cyclic: 20 mg qd for last 12 days of cycle
- Paroxetine (Paxil) 10-20 mg qd
- Sertraline (Zoloft) 50-100 mg qd
- References
- Step 7: Anxiolytic trial
- Second-line agents for failed SSRI trial
- Buspirone
- Daily: 5-20 mg qd throughout cycle OR
- Cyclic: 5-20 mg qd for last 12 days of cycle
- Benzodiazepines
- Addictive potential (use only for refractory cases)
- Not recommended
- Clonazepam 0.5 mg qhs to tid on premenstrual days
- Step 8: Pharmacologic Ovarian Suppression
- GnRH agonist (very expensive: $500 per month)
- Leuprolide (Depo Lupron) 3.75 mg IM monthly or
- Leuprolide (Depo Lupron) 11.25 mg IM q3 months or
- Goserelin (Zoladex) 3.6 mg SQ qMonth or
- Goserelin (Zoladex) 10.8 mg SQ q3 months or
- Nafarelin (Synarel) 200 to 400 mcg intranasal bid
- Concurrently add back Estrogen Replacement
- Indicated if GnRH agonist used for >6 months
- Estrogen (Premarin) 6.25 mg qd and
- Provera 2.5 mg PO qd if intact uterus
- GnRH agonist (very expensive: $500 per month)
- Step 9: Consider Oophorectomy
- Step 0
- Resources
- PMS Access
- Phone: (800) 222-4PMS
- PMS Access
- References
- Ransom (1998) Physician and Sportsmed 26(4):35-43
- Rapkin (1999) Fam Pract Recert 21(1):42-73
- (2000) Obstet Gynecol 95:1
- Bhatia (2002) Am Fam Physician 66:1239
- Daugherty (1998) Am Fam Physician 58(1):183
- Dickerson (2003) Am Fam Physician 67(8):1743
Premenstrual syndrome (C0033046) | |
|---|---|
| Definition (MSH) | A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses. |
| Definition (CSP) | occurs in some women prior to menstruation; salt and water retention cause weight gain and bloating; individuals may experience mood changes. |
| Concepts | Disease or Syndrome (T047) |
| ICD9 | 625.4 |
| English | Menstrual molimen, PMS, Premenstrual Syndrome, Premenstrual Syndromes, SYNDROME PREMENSTRUAL |
| Spanish | SPM |
| Credits | Derived from the NIH UMLS (Unified Medical Language System) |
